EDITORIALS

Optimal Therapy for Unresectable Stage III Non–Small-Cell Lung Cancer

Everett E. Vokes

JCO Sep 1 2005: 5853–5855. First published on Aug 8 2005; 10.1200/JCO.2005.95.028. [Full Text] [PDF]

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Plus Chemotherapy: Case Closed or Is the Jury Still Out?

David R. Gandara and Paul H. Gumerlock

JCO Sep 1 2005: 5856–5858. First published on Jul 25 2005; 10.1200/JCO.2005.05.030. [Full Text] [PDF]

Will Future Progress in Non–Small-Cell Lung Cancer Be Step by Step ... or by Leaps and Bounds?

Benjamin Movsas

JCO Sep 1 2005: 5859–5861. First published on Aug 8 2005; 10.1200/JCO.2005.05.035. [Full Text] [PDF]

CA-125 and Early Ovarian Cancer: Does This Help the Clinician or Further Muddy the Water?

William P. McGuire

JCO Sep 1 2005: 5862–5864. First published on Aug 8 2005; 10.1200/JCO.2005.05.027. [Full Text] [PDF]

Erythropoietin Use in Cancer Patients: A Matter of Life and Death?

David P. Steensma and Charles L. Loprinzi

JCO Sep 1 2005: 5865–5868. First published on Aug 8 2005; 10.1200/JCO.2005.05.036. [Full Text] [PDF]

Ovarian Suppression for Breast Cancer: An Effective Treatment in Search of a Home

Ian E. Krop and Eric P. Winer

JCO Sep 1 2005: 5869–5872. First published on Aug 8 2005; 10.1200/JCO.2005.06.002. [Full Text] [PDF]

"Will Weekly Work"? Seems to Be So...

Andrew D. Seidman

JCO Sep 1 2005: 5873–5874. First published on Aug 8 2005; 10.1200/JCO.2005.05.031. [Full Text] [PDF]

Self-Recognition and Tumor Response to Immunotherapy

Marc S. Ernstoff

JCO Sep 1 2005: 5875–5877. First published on Aug 8 2005; 10.1200/JCO.2005.95.029. [Full Text] [PDF]

Depression and Survival After Hematopoietic Stem Cell Transplantation: Where Do We Go From Here?

Michael A. Andrykowski

JCO Sep 1 2005: 5878–5880. First published on Aug 8 2005; 10.1200/JCO.2005.95.037. [Full Text] [PDF]

Practice Variation: The Achilles' Heel in Quality Cancer Care

David M. Dilts

JCO Sep 1 2005: 5881–5882. First published on Aug 8 2005; 10.1200/JCO.2005.05.034. [Full Text] [PDF] [Publisher's Note]

ORIGINAL REPORTS
Lung Cancer
	Combined Chemoradiotherapy Regimens of Paclitaxel and Carboplatin for Locally Advanced Non–Small-Cell Lung Cancer: A Randomized Phase II Locally Advanced Multi-Modality Protocol
	Chandra P. Belani, Hak Choy, Phil Bonomi, Charles Scott, Patrick Travis, John Haluschak, and Walter J. Curran, Jr
	JCO Sep 1 2005: 5883–5891. First published on Aug 8 2005; 10.1200/JCO.2005.55.405. [Abstract] [Full Text] [PDF] [Publisher's Note]
	TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer
	Roy S. Herbst, Diane Prager, Robert Hermann, Lou Fehrenbacher, Bruce E. Johnson, Alan Sandler, Mark G. Kris, Hai T. Tran, Pam Klein, Xin Li, David Ramies, David H. Johnson, and Vincent A. Miller
	JCO Sep 1 2005: 5892–5899. First published on Jul 25 2005; 10.1200/JCO.2005.02.840. [Abstract] [Full Text] [PDF] [Editor's Note]
	Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib
	David A. Eberhard, Bruce E. Johnson, Lukas C. Amler, Audrey D. Goddard, Sherry L. Heldens, Roy S. Herbst, William L. Ince, Pasi A. Jänne, Thomas Januario, David H. Johnson, Pam Klein, Vincent A. Miller, Michael A. Ostland, David A. Ramies, Dragan Sebisanovic, Jeremy A. Stinson, Yu R. Zhang, Somasekar Seshagiri, and Kenneth J. Hillan
	JCO Sep 1 2005: 5900–5909. First published on Jul 25 2005; 10.1200/JCO.2005.02.857. [Abstract] [Full Text] [PDF] [Publisher's Note] [Editor's Note]
	Randomized Phase III Trial of Sequential Chemoradiotherapy Compared With Concurrent Chemoradiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique–Groupe Français de Pneumo-Cancérologie NPC 95-01 Study
	Pierre Fournel, Gilles Robinet, Pascal Thomas, Pierre-Jean Souquet, Hervé Léna, Alain Vergnenégre, Jean-Yves Delhoume, Jacques Le Treut, Jules-Antoine Silvani, Eric Dansin, Marie-Cécile Bozonnat, Jean-Pierre Daurés, Françoise Mornex, and Maurice Pérol
	JCO Sep 1 2005: 5910–5917. First published on Aug 8 2005; 10.1200/JCO.2005.03.070. [Abstract] [Full Text] [PDF]
	Phase II Multicenter Study of Induction Chemotherapy Followed by Concurrent Efaproxiral (RSR13) and Thoracic Radiotherapy for Patients With Locally Advanced Non–Small-Cell Lung Cancer
	Hak Choy, Abdenour Nabid, Baldassarre Stea, Charles Scott, Wilson Roa, Larry Kleinberg, Joseph Ayoub, Colum Smith, Luis Souhami, Solomon Hamburg, William Spanos, Harvey Kreisman, Adam P. Boyd, Pablo J. Cagnoni, and Walter J. Curran
	JCO Sep 1 2005: 5918–5928. [Abstract] [Full Text] [PDF]
	Randomized Phase II Trial of Three Schedules of Pemetrexed and Gemcitabine As Front-Line Therapy for Advanced Non–Small-Cell Lung Cancer
	Cynthia X. Ma, Suresh Nair, Sachdev Thomas, Sumithra J. Mandrekar, Daniel A. Nikcevich, Kendrith M. Rowland, Tom R. Fitch, Harold E. Windschitl, Shauna L. Hillman, Steven E. Schild, James R. Jett, Coleman Obasaju, and Alex A. Adjei
	JCO Sep 1 2005: 5929–5937. [Abstract] [Full Text] [PDF]

Gynecologic Cancer
	Prognostic Importance of Preoperative CA-125 in International Federation of Gynecology and Obstetrics Stage I Epithelial Ovarian Cancer: An Australian Multicenter Study
	Sellva Paramasivam, Lee Tripcony, Alex Crandon, Micheal Quinn, Ian Hammond, Donald Marsden, Anthony Proietto, Margaret Davy, Jonathan Carter, James Nicklin, Lewis Perrin, and Andreas Obermair
	JCO Sep 1 2005: 5938–5942. First published on Aug 8 2005; 10.1200/JCO.2005.08.151. [Abstract] [Full Text] [PDF]
	Phase I Trial of Bortezomib and Carboplatin in Recurrent Ovarian or Primary Peritoneal Cancer
	C. Aghajanian, D.S. Dizon, P. Sabbatini, J.J. Raizer, J. Dupont, and D.R. Spriggs
	JCO Sep 1 2005: 5943–5949. [Abstract] [Full Text] [PDF]
	Study of Etanercept, a Tumor Necrosis Factor-Alpha Inhibitor, in Recurrent Ovarian Cancer
	Srinivasan Madhusudan, Sethupathi R. Muthuramalingam, Jeremy P. Braybrooke, Susan Wilner, Kulwinder Kaur, Cheng Han, Susan Hoare, Frances Balkwill, and Trivadi S. Ganesan
	JCO Sep 1 2005: 5950–5959. [Abstract] [Full Text] [PDF]

Breast Cancer
	Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study
	Brian Leyland-Jones, Vladimir Semiglazov, Marek Pawlicki, Tadeusz Pienkowski, Sergei Tjulandin, George Manikhas, Antoly Makhson, Anton Roth, David Dodwell, Jose Baselga, Mikhail Biakhov, Konstantinas Valuckas, Edouard Voznyi, Xiangyang Liu, and Els Vercammen
	JCO Sep 1 2005: 5960–5972. First published on Aug 8 2005; 10.1200/JCO.2005.06.150. [Abstract] [Full Text] [PDF]
	Chemoendocrine Therapy for Premenopausal Women With Axillary Lymph Node–Positive, Steroid Hormone Receptor–Positive Breast Cancer: Results From INT 0101 (E5188)
	Nancy E. Davidson, Anne M. O'Neill, Allen M. Vukov, C. Kent Osborne, Silvana Martino, Douglas R. White, and Martin D. Abeloff
	JCO Sep 1 2005: 5973–5982. First published on Aug 8 2005; 10.1200/JCO.2005.05.551. [Abstract] [Full Text] [PDF] [Publisher's Note]
	Weekly Paclitaxel Improves Pathologic Complete Remission in Operable Breast Cancer When Compared With Paclitaxel Once Every 3 Weeks
	Marjorie C. Green, Aman U. Buzdar, Terry Smith, Nuhad K. Ibrahim, Vicente Valero, Marguerite F. Rosales, Massimo Cristofanilli, Daniel J. Booser, Lajos Pusztai, Edgardo Rivera, Richard L. Theriault, Cynthia Carter, Debra Frye, Kelly K. Hunt, W. Fraser Symmans, Eric A. Strom, Aysegul A. Sahin, William Sikov, and Gabriel N. Hortobagyi
	JCO Sep 1 2005: 5983–5992. First published on Aug 8 2005; 10.1200/JCO.2005.06.232. [Abstract] [Full Text] [PDF]
	Prospective Multicenter Validation of the Independent Prognostic Value of the Mitotic Activity Index in Lymph Node–Negative Breast Cancer Patients Younger Than 55 Years
	Jan P.A. Baak, Paul J. van Diest, Feja J. Voorhorst, Elsken van der Wall, Louk V.A.M. Beex, Jan B. Vermorken, and Emiel A.M. Janssen
	JCO Sep 1 2005: 5993–6001. [Abstract] [Full Text] [PDF]
	Incidence and Prognostic Impact of Amenorrhea During Adjuvant Therapy in High-Risk Premenopausal Breast Cancer: Analysis of a National Cancer Institute of Canada Clinical Trials Group Study—NCIC CTG MA.5
	Wendy R. Parulekar, Andrew G. Day, Jon A. Ottaway, Lois E. Shepherd, Maureen E. Trudeau, Vivien Bramwell, Mark Levine, and Kathleen I. Pritchard
	JCO Sep 1 2005: 6002–6008. [Abstract] [Full Text] [PDF]
	Outcomes From the Moving Beyond Cancer Psychoeducational, Randomized, Controlled Trial With Breast Cancer Patients
	Annette L. Stanton, Patricia A. Ganz, Lorna Kwan, Beth E. Meyerowitz, Julienne E. Bower, Janice L. Krupnick, Julia H. Rowland, Beth Leedham, and Thomas R. Belin
	JCO Sep 1 2005: 6009–6018. [Abstract] [Full Text] [PDF]
	Multicenter Phase II Trial of ABI-007, an Albumin-Bound Paclitaxel, in Women With Metastatic Breast Cancer
	Nuhad K. Ibrahim, Brian Samuels, Ray Page, Dinesh Doval, Kirtikumar M. Patel, S.C. Rao, Madhavan Krishnan Nair, Paul Bhar, Neil Desai, and Gabriel N. Hortobagyi
	JCO Sep 1 2005: 6019–6026. [Abstract] [Full Text] [PDF]
	Randomized Controlled Trial of an Educational Intervention for Managing Fatigue in Women Receiving Adjuvant Chemotherapy for Early-Stage Breast Cancer
	Patsy Yates, Sanchia Aranda, Maryanne Hargraves, Bev Mirolo, Alexandra Clavarino, SueAnne McLachlan, and Helen Skerman
	JCO Sep 1 2005: 6027–6036. [Abstract] [Full Text] [PDF]
	Is Leptin a Mediator of Adverse Prognostic Effects of Obesity in Breast Cancer?
	Pamela J. Goodwin, Marguerite Ennis, I. George Fantus, Kathleen I. Pritchard, Maureen E. Trudeau, Jarley Koo, and Nicky Hood
	JCO Sep 1 2005: 6037–6042. [Abstract] [Full Text] [PDF]

Melanoma
	Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4
	Peter Attia, Giao Q. Phan, Ajay V. Maker, Michael R. Robinson, Martha M. Quezado, James C. Yang, Richard M. Sherry, Suzanne L. Topalian, Udai S. Kammula, Richard E. Royal, Nicholas P. Restifo, Leah R. Haworth, Catherine Levy, Sharon A. Mavroukakis, Geoff Nichol, Michael J. Yellin, and Steven A. Rosenberg
	JCO Sep 1 2005: 6043–6053. First published on Aug 8 2005; 10.1200/JCO.2005.06.205. [Abstract] [Full Text] [PDF]
	Population-Based Assessment of Surgical Treatment Trends for Patients With Melanoma in the Era of Sentinel Lymph Node Biopsy
	Janice N. Cormier, Yan Xing, Meichun Ding, Jeffrey E. Lee, Paul F. Mansfield, Jeffrey E. Gershenwald, Merrick I. Ross, and Xianglin L. Du
	JCO Sep 1 2005: 6054–6062. [Abstract] [Full Text] [PDF]

Supportive Care and Quality of Life
	Role of Depression As a Predictor of Mortality Among Cancer Patients After Stem-Cell Transplantation
	Jesús M. Prieto, Jorge Atala, Jordi Blanch, Enric Carreras, Montserrat Rovira, Esteve Cirera, Anna Espinal, and Cristóbal Gasto
	JCO Sep 1 2005: 6063–6071. First published on Aug 8 2005; 10.1200/JCO.2005.05.751. [Abstract] [Full Text] [PDF]
	Survival in Patients Operated on for Pathologic Fracture: Implications for End-of-Life Orthopedic Care
	Saminathan S. Nathan, John H. Healey, Danilo Mellano, Bang Hoang, Isobel Lewis, Carol D. Morris, Edward A. Athanasian, and Patrick J. Boland
	JCO Sep 1 2005: 6072–6082. [Abstract] [Full Text] [PDF]
	Randomized Study on the Efficacy of Cognitive-Behavioral Therapy for Insomnia Secondary to Breast Cancer, Part I: Sleep and Psychological Effects
	Josée Savard, Sébastien Simard, Hans Ivers, and Charles M. Morin
	JCO Sep 1 2005: 6083–6096. [Abstract] [Full Text] [PDF]
	Randomized Study on the Efficacy of Cognitive-Behavioral Therapy for Insomnia Secondary to Breast Cancer, Part II: Immunologic Effects
	Josée Savard, Sébastien Simard, Hans Ivers, and Charles M. Morin
	JCO Sep 1 2005: 6097–6106. [Abstract] [Full Text] [PDF]

Phase I and Clinical Pharmacology
	Proteasome Inhibition With Bortezomib (PS-341): A Phase I Study With Pharmacodynamic End Points Using a Day 1 and Day 4 Schedule in a 14-Day Cycle
	A.L. Hamilton, J.P. Eder, A.C. Pavlick, J.W. Clark, L. Liebes, R. Garcia-Carbonero, A. Chachoua, D.P. Ryan, V. Soma, K. Farrell, N. Kinchla, J. Boyden, H. Yee, A. Zeleniuch-Jacquotte, J. Wright, P. Elliott, J. Adams, and F.M. Muggia
	JCO Sep 1 2005: 6107–6116. [Abstract] [Full Text] [PDF]
	Associations Between Drug Metabolism Genotype, Chemotherapy Pharmacokinetics, and Overall Survival in Patients With Breast Cancer
	William P. Petros, Penelope J. Hopkins, Susan Spruill, Gloria Broadwater, James J. Vredenburgh, O. Michael Colvin, William P. Peters, Roy B. Jones, Jeff Hall, and Jeffrey R. Marks
	JCO Sep 1 2005: 6117–6125. First published on Aug 8 2005; 10.1200/JCO.2005.06.075. [Abstract] [Full Text] [PDF]

Radiation Oncology
	Occurrence of Second Cancers in Patients Treated With Radiotherapy for Rectal Cancer
	Helgi Birgisson, Lars Påhlman, Ulf Gunnarsson, and Bengt Glimelius
	JCO Sep 1 2005: 6126–6131. [Abstract] [Full Text] [PDF]

Genitourinary Cancer
	Randomized Trial Comparing Two Fractionation Schedules for Patients With Localized Prostate Cancer
	Himu Lukka, Charles Hayter, Jim A. Julian, Padraig Warde, W. James Morris, Mary Gospodarowicz, Mark Levine, Jinka Sathya, Richard Choo, Hugh Prichard, Michael Brundage, and Winkle Kwan
	JCO Sep 1 2005: 6132–6138. [Abstract] [Full Text] [PDF]
	Is Prostate-Specific Antigen a Valid Surrogate End Point for Survival in Hormonally Treated Patients With Metastatic Prostate Cancer? Joint Research of the European Organisation for Research and Treatment of Cancer, the Limburgs Universitair Centrum, and AstraZeneca Pharmaceuticals
	Laurence Collette, Tomasz Burzykowski, Kevin J. Carroll, Don Newling, Tom Morris, and Fritz H. Schröder
	JCO Sep 1 2005: 6139–6148. [Abstract] [Full Text] [PDF]
	Outcome Analysis for Patients With Elevated Serum Tumor Markers at Postchemotherapy Retroperitoneal Lymph Node Dissection
	Stephen D.W. Beck, Richard S. Foster, Richard Bihrle, Lawrence H. Einhorn, and John P. Donohue
	JCO Sep 1 2005: 6149–6156. [Abstract] [Full Text] [PDF]
	Preoperative PSA Velocity Is an Independent Prognostic Factor for Relapse After Radical Prostatectomy
	Deep A. Patel, Joseph C. Presti, Jr, John E. McNeal, Harcharan Gill, James D. Brooks, and Christopher R. King
	JCO Sep 1 2005: 6157–6162. [Abstract] [Full Text] [PDF]

Hematologic Malignancies
	Durable Clinical, Cytogenetic, and Molecular Remissions After Allogeneic Hematopoietic Cell Transplantation for Refractory Sezary Syndrome and Mycosis Fungoides
	Arturo Molina, Jasmine Zain, Daniel A. Arber, Maria Angelopolou, Margaret O’Donnell, Joyce Murata-Collins, Stephen J. Forman, and Auayporn Nademanee
	JCO Sep 1 2005: 6163–6171. [Abstract] [Full Text] [PDF]

Pediatric Oncology
	Phase I and Pharmacokinetic Study of Gefitinib in Children With Refractory Solid Tumors: A Children’s Oncology Group Study
	Najat C. Daw, Wayne L. Furman, Clinton F. Stewart, Lisa C. Iacono, Mark Krailo, Mark L. Bernstein, Janet E. Dancey, Rose Anne Speights, Susan M. Blaney, James M. Croop, Gregory H. Reaman, and Peter C. Adamson
	JCO Sep 1 2005: 6172–6180. [Abstract] [Full Text] [PDF]
	Salvage Therapy of Progressive and Recurrent Hodgkin’s Disease: Results From a Multicenter Study of the Pediatric DAL/GPOH-HD Study Group
	Günther Schellong, Wolfgang Dörffel, Alexander Claviez, Dieter Körholz, Georg Mann, Hans-G. Scheel-Walter, Jos P.M. Bökkerink, Marianne Riepenhausen, Heike Lüders, Richard Pötter, and Ursula Rühl
	JCO Sep 1 2005: 6181–6189. [Abstract] [Full Text] [PDF]

Sarcomas
	Deletions Affecting Codons 557-558 of the c-KIT Gene Indicate a Poor Prognosis in Patients With Completely Resected Gastrointestinal Stromal Tumors: A Study by the Spanish Group for Sarcoma Research (GEIS)
	Javier Martín, Andrés Poveda, Antonio Llombart-Bosch, Rafael Ramos, José A. López-Guerrero, Javier García del Muro, Joan Maurel, Silvia Calabuig, Antonio Gutierrez, José L. González de Sande, Javier Martínez, Ana De Juan, Nuria Laínez, Ferrán Losa, Valentín Alija, Pilar Escudero, Antonio Casado, Pilar García, Remei Blanco, and José M. Buesa
	JCO Sep 1 2005: 6190–6198. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Late Side Effects of Short-Course Preoperative Radiotherapy Combined With Total Mesorectal Excision for Rectal Cancer: Increased Bowel Dysfunction in Irradiated Patients—A Dutch Colorectal Cancer Group Study
	K.C.M.J. Peeters, C.J.H. van de Velde, J.W.H. Leer, H. Martijn, J.M.C. Junggeburt, E. Klein Kranenbarg, W.H. Steup, T. Wiggers, H.J. Rutten, and C.A.M. Marijnen
	JCO Sep 1 2005: 6199–6206. [Abstract] [Full Text] [PDF]

REVIEW ARTICLES
	Current Management of Brain Metastases, With a Focus on Systemic Options
	Corey J. Langer and Minesh P. Mehta
	JCO Sep 1 2005: 6207–6219. [Abstract] [Full Text] [PDF]
	Adjuvant Therapy in Gastric Cancer
	Lionel Lim, Michael Michael, G. Bruce Mann, and Trevor Leong
	JCO Sep 1 2005: 6220–6232. [Abstract] [Full Text] [PDF]

SPECIAL ARTICLES
	A Process for Measuring the Quality of Cancer Care: The Quality Oncology Practice Initiative
	Michael N. Neuss, Christopher E. Desch, Kristen K. McNiff, Peter D. Eisenberg, Dean H. Gesme, Joseph O. Jacobson, Mohammad Jahanzeb, Jennifer J. Padberg, John M. Rainey, Jeff J. Guo, and Joseph V. Simone
	JCO Sep 1 2005: 6233–6239. First published on Aug 8 2005; 10.1200/JCO.2005.05.948. [Abstract] [Full Text] [PDF]
	Prognostic Factors in Advanced Cancer Patients: Evidence-Based Clinical Recommendations—A Study by the Steering Committee of the European Association for Palliative Care
	Marco Maltoni, Augusto Caraceni, Cinzia Brunelli, Bert Broeckaert, Nicholas Christakis, Steffen Eychmueller, Paul Glare, Maria Nabal, Antonio Viganò, Philip Larkin, Franco De Conno, Geoffrey Hanks, and Stein Kaasa
	JCO Sep 1 2005: 6240–6248. [Abstract] [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Uncommon Malignancies: CASE 1. Low-Grade Myofibroblastic Sarcoma of the Breast

Peter B. Morgan, Satish Chundru, Sandra S. Hatch, Hal K. Hawkins, Patrick A. Adegboyega, and Mahmoud A. Eltorky

JCO Sep 1 2005: 6249–6251. [Full Text] [PDF]

Uncommon Malignancies: CASE 2. Gastric Choriocarcinoma

Daniel W. Dye, Ralph Broadwater, and Laura W. Lamps

JCO Sep 1 2005: 6251–6253. [Full Text] [PDF]

Uncommon Malignancies: CASE 3. Paratesticular Desmoplastic Small Round-Cell Tumor

Rodolphe Thuret, Karine Renaudin, Jérôme Leclere, Simon Battisti, Olivier Bouchot, and Christine Theodore

JCO Sep 1 2005: 6253–6255. [Full Text] [PDF]

ART OF ONCOLOGY

To Feed or Not to Feed: Is That the Right Question?

Timothy Moynihan, Darlene G. Kelly, and Michael J. Fisch

JCO Sep 1 2005: 6256–6259. [Full Text] [PDF]

SPECIAL DEPARTMENTS

Correspondence

What Is the Best Chemotherapy Treatment Option for Anthracycline and Taxane Pretreated Metastatic Breast Cancer?

Sunil Verma, Maureen Trudeau, George Dranitsaris, Mark Clemons, Anil A. Joy, and John R. MacKey

JCO Sep 1 2005: 6260. [Full Text] [PDF]

In Reply:

Alan M. Keller

JCO Sep 1 2005: 6261. [Full Text] [PDF]

Effects of Pretransplantation Treatment With Rituximab on Outcomes of Autologous Stem-Cell Transplantation for Non-Hodgkin's Lymphoma

Saad Akhtar and Irfan Maghfoor

JCO Sep 1 2005: 6261-a. [Full Text] [PDF]

In Reply:

Hanna J. Khoury and John F. DiPersio

JCO Sep 1 2005: 6262. [Full Text] [PDF]

Event-Free Survival of Patients With High-Risk Neuroblastoma Treated With an N6-Like Induction Treatment

Dominique Valteau-Couanet

JCO Sep 1 2005: 6262-a–6263. [Full Text] [PDF]

In Reply:

Brian H. Kushner, Kim Kramer, Michael P. Laquaglia, Shakeel Modak, Karima Yataghene, and Nai-Kong V. Cheung

JCO Sep 1 2005: 6263. [Full Text] [PDF]

Should We Transplant Indolent Lymphoma?

Chadi Nabhan

JCO Sep 1 2005: 6263-a–6264. [Full Text] [PDF]

In Reply:

Georg Lenz, Martin Dreyling, Michael Unterhalt, and Wolfgang Hiddemann

JCO Sep 1 2005: 6264–6266. [Full Text] [PDF]

Sequential or Concurrent Tamoxifen and Radiotherapy: To See or Not to See—That Is the Question!

Søren M. Bentzen and John R. Yarnold

JCO Sep 1 2005: 6266–6267. [Full Text] [PDF]

In Reply:

Timothy Whelan and Mark Levine

JCO Sep 1 2005: 6267. [Full Text] [PDF]

High-Dose Interleukin-2 May Not Be Superior to Low-Dose Interleukin-2 Plus Interferon

Mir Alikhan, Horace J. Spencer, and Manish Kohli

JCO Sep 1 2005: 6267-a–6268. [Full Text] [PDF]

In Reply:

David F. McDermott and Meredith M. Regan

JCO Sep 1 2005: 6268–6269. [Full Text] [PDF]

Is the Tolerance to MIP Chemotherapy Different Between English and Other European Populations?

T. Berghmans and J.P. Sculier

JCO Sep 1 2005: 6269–6270. [Full Text] [PDF]

In Reply:

R.M. Rudd, N.H. Gower, S.G. Spiro, S.M. Lee, T.G. Eisen, P.G. Harper, M. Hatton, W.M.C. Martin, and E.M. Rankin

JCO Sep 1 2005: 6270–6271. [Full Text] [PDF]

Imatinib Mesylate Can Induce Objective Response in Progressing, Highly Expressing KIT Adenoid Cystic Carcinoma of the Salivary Glands

Sandrine Faivre, Eric Raymond, Odile Casiraghi, Stéphane Temam, and Patrice Berthaud

JCO Sep 1 2005: 6271–6273. [Full Text] [PDF]

In Reply:

Sébastien J. Hotte, Anthony J. Murgo, and Lillian L. Siu

JCO Sep 1 2005: 6273–6274. [Full Text] [PDF]

Target-Treatment and Patients' Selection: Can We Still Neglect the Timing of Tissue Collection?

Tommaso De Pas, Carlo Putzu, Giuseppe Pelosi, Giuseppe Curigliano, Cristina Noberasco, Giulia Zampino, Nicola Fazio, Vincenzo Formica, Lorenzo Spaggiari, and Filippo de Braud

JCO Sep 1 2005: 6274–6275. [Full Text] [PDF]

In Reply:

Leonard B. Saltz and Ki Young Chung

JCO Sep 1 2005: 6275–6276. [Full Text] [PDF]

Platinum-Based Versus Non–Platinum-Based Chemotherapy in Advanced Non–Small-Cell Lung Cancer: Does Cisplatin Versus Carboplatin Make a Difference?

Marcello Tiseo, Luca Boni, and Andrea Ardizzoni

JCO Sep 1 2005: 6276–6277. [Full Text] [PDF]

In Reply:

Giannicola D'Addario, Melania Pintilie, and Frances A. Shepherd

JCO Sep 1 2005: 6277–6278. [Full Text] [PDF]

Regression of Colorectal Adenomas With Intravenous Cytotoxic Chemotherapy in a Patient With Familial Adenomatous Polyposis

Douglas H. Jones, Peter T. Silberstein, Henry Lynch, and Charles Ternet

JCO Sep 1 2005: 6278–6280. [Full Text] [PDF]

Errata

ERRATUM

JCO Sep 1 2005: 6281. [Full Text] [PDF]

ERRATUM

JCO Sep 1 2005: 6281-a. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.